Literature DB >> 18725588

Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?

Herbert Schaumburg, Steven Herskovitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725588     DOI: 10.1212/01.wnl.0000324620.86645.c1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Copper(II) Binding to PBT2 Differs from That of Other 8-Hydroxyquinoline Chelators: Implications for the Treatment of Neurodegenerative Protein Misfolding Diseases.

Authors:  Kelly L Summers; Graham P Roseman; George J Sopasis; Glenn L Millhauser; Hugh H Harris; Ingrid J Pickering; Graham N George
Journal:  Inorg Chem       Date:  2020-11-23       Impact factor: 5.165

2.  Pharmacological activity of metal binding agents that alter copper bioavailability.

Authors:  Marian E Helsel; Katherine J Franz
Journal:  Dalton Trans       Date:  2015-05-21       Impact factor: 4.390

Review 3.  Mapping brain metals to evaluate therapies for neurodegenerative disease.

Authors:  Bogdan Florin Gh Popescu; Helen Nichol
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

4.  Copper Deficiency Myeloneuropathy Following Roux-en-Y Gastric Bypass in a 72-Year-Old Female.

Authors:  Zachary Kirkland; Ricardo J Villasmil; Jeffrey Alookaran; Mindy C Ward; David Stone
Journal:  Cureus       Date:  2022-05-18

Review 5.  Copper deficiency myelopathy.

Authors:  Stephan R Jaiser; Gavin P Winston
Journal:  J Neurol       Date:  2010-03-16       Impact factor: 4.849

6.  Approach to a case of myeloneuropathy.

Authors:  Ravindra Kumar Garg; Hardeep Singh Malhotra; Neeraj Kumar
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

7.  Founder genetic variants of ABCC4 and ABCC11 in the Japanese population are not associated with the development of subacute myelo-optico-neuropathy (SMON).

Authors:  Hideki Matsumoto; Hideo Sasai; Norio Kawamoto; Masato Katsuyama; Makoto Minamiyama; Satoshi Kuru; Toshiyuki Fukao; Hidenori Ohnishi
Journal:  Mol Genet Genomic Med       Date:  2021-12-24       Impact factor: 2.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.